Publication | Closed Access

95 Phase III trial of adjuvant androgen suppression using goserelin in patients with carcinoma of the prostate treated with definitive radiotherapy (results of RTOG 85-31)

Adjuvant Androgen SuppressionUrologyMedicinePhase Iii TrialBenign Prostatic HyperplasiaRtog 85-31Prostatic DiseaseOncologyRadiation Oncology